← Back to Search

Writing Therapy for Cancer Survivors

N/A
Recruiting
Led By Qian Lu, MD, PHD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to understand the experiences of Asian American immigrant breast cancer survivors and how writing about their experiences may impact their health."

Who is the study for?
This trial is for Asian American breast cancer survivors who have immigrated to the United States. It's designed to understand their experiences and how writing about these experiences can impact their health.
What is being tested?
Participants will be asked to complete questionnaires and write essays as a form of therapy. The study aims to evaluate if this writing therapy can provide health benefits for cancer survivors.
What are the potential side effects?
Since the intervention involves writing, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention ConditionExperimental Treatment2 Interventions
Participants will be asked to write about different topics regarding their cancer experience. During session 1, participants will be asked to write about the stress of having cancer and their strategies for coping with stressors associated with their cancer (i.e., stress and coping). During session 2, participants will be asked to write about their deepest feelings regarding their cancer experience (i.e., emotional disclosure). During session 3 and the booster session (at 9-month follow-up), participants will be asked to write about positive thoughts and feelings regarding their experience with cancer.
Group II: Control conditionExperimental Treatment2 Interventions
Participants will be asked to write about facts regarding their cancer diagnosis and treatment in writing sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Questionnaires
2013
Completed Phase 2
~4280

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,059 Previous Clinical Trials
1,800,476 Total Patients Enrolled
Qian Lu, MD, PHDPrincipal InvestigatorM.D. Anderson Cancer Center
~114 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top